Indonesia vs United Arab Emirates: The number of people with susceptibility test result for rifampicin
Indonesia
72.55
in 2021
United Arab Emirates
69.7
in 2021
Indonesia rank
102nd
United Arab Emirates rank
104th
The number of people with susceptibility test result for rifampicin over time
- Indonesia
- United Arab Emirates
How they compare
Indonesia currently reports 72.55 against 69.7 in United Arab Emirates, a difference of 2.85.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was United Arab Emirates ahead.
Indonesia ranks 102nd and United Arab Emirates ranks 104th of 146 countries.
United Arab Emirates has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Indonesia | United Arab Emirates | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 30.84 | 72.12 | 41.28 | United Arab Emirates |
| 2020s | 65.06 | 80.16 | 15.1 | United Arab Emirates |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Indonesia or United Arab Emirates?
- Indonesia, at 72.55 against 69.7 in United Arab Emirates as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Indonesia and United Arab Emirates?
- 2.85, with Indonesia ahead.
- How many years of comparable data are there for Indonesia and United Arab Emirates?
- 5 years are reported by both, from 2017 to 2021.
- How do Indonesia and United Arab Emirates rank globally for the number of people with susceptibility test result for rifampicin?
- Indonesia ranks 102nd and United Arab Emirates ranks 104th of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.